FMC (FMC) AI Stock Analysis

• Market Cap: $3.81B
• Dividend Yield: 7.57%
• Average Volume (3M): 2.30M
• Price to Earnings (P/E): 38.8
• Beta (1Y): 0.98
• Revenue Growth: 1.16%
• EPS Growth: -92.85%
• Country: US
• Employees: 5,700
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): N/A
• Shares Outstanding: 124,911,580
• 10 Day Avg. Volume: 1,944,040
• 30 Day Avg. Volume: 2,300,872
• PEG Ratio: -0.24
• Price to Book (P/B): 1.35
• Price to Sales (P/S): 1.43
• P/FCF Ratio: 10.07
• Enterprise Value/Market Cap: 2.39
• Enterprise Value/Revenue: 2.21
• Enterprise Value/Gross Profit: 5.58
• Enterprise Value/Ebitda: 12.79
• 1Y Price Target: $41.08
• Price Target Upside: 34.51% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 12

• Rating: 58 Neutral
• Price Target: $39.00 ▲(27.70% Upside)

FMC's overall stock score reflects a combination of mixed financial performance, bearish technical indicators, and valuation concerns. The earnings call provided some positive insights, particularly regarding new product growth and regional performance in EMEA, but challenges in key markets and pricing pressures remain significant risks.

Positive Factors

Strong Growth in EMEA Region

The strong growth in the EMEA region indicates a robust market position and effective product strategy, contributing to long-term revenue stability and expansion opportunities.

Promising Outlook for New Products

The introduction of new active ingredients like fluindapyr and Isoflex supports future growth, enhancing FMC's competitive edge and product portfolio diversification.

Successful Debt Management

Effective debt management improves financial stability and flexibility, allowing FMC to better navigate market fluctuations and invest in growth initiatives.

Negative Factors

Challenges in India Market

The divestment in India reflects significant operational challenges, potentially limiting FMC's market reach and revenue diversification in a key region.

Pricing Pressures

Ongoing pricing pressures could erode profit margins, impacting FMC's ability to sustain profitability and invest in future growth.

North America Sales Decline

Declining sales in North America highlight demand volatility and potential market saturation, posing risks to FMC's revenue consistency and growth prospects.

FMC Business Overview & Revenue Model

Company Description

FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.

How the Company Makes Money

FMC generates revenue through the sale of its crop protection products and solutions. The company's primary revenue streams include the sale of insecticides, herbicides, and fungicides, which are essential for protecting crops from pests and diseases. Additionally, FMC offers specialty products that enhance crop yield and quality, further contributing to its earnings. The company benefits from significant partnerships with agricultural distributors and retailers, allowing it to reach a broad customer base in various markets. Furthermore, FMC invests in research and development to innovate and expand its product portfolio, which helps to drive sales and maintain competitiveness in the agricultural industry.

FMC Financial Statement Overview

Summary

FMC shows moderate financial health with declining revenue and profit margins, indicating challenges in growth and operational efficiency. The balance sheet is stable with manageable debt, but cash flow generation is concerning due to significant declines in free cash flow.

Income Statement

The TTM revenue of $4.12 billion shows a decline from the previous year's $4.49 billion, indicating a negative revenue growth rate. The gross profit margin is approximately 39.3%, showing strong profitability but with a slight decline from previous periods. The net profit margin stands at 8.1%, showing moderate profitability. However, EBIT and EBITDA margins have decreased, suggesting potential challenges in operational efficiency.

Balance Sheet

The debt-to-equity ratio is moderate at 0.22, indicating a balanced approach to leverage. The return on equity (ROE) is approximately 7.6%, which is relatively low, suggesting room for improvement in generating returns for shareholders. The equity ratio is around 37.1%, showing a stable capital structure with a healthy equity base.

Cash Flow

The free cash flow has decreased significantly from $603.2 million to $243.3 million, indicating a substantial negative growth rate. The operating cash flow to net income ratio is 0.87, which is below optimal levels, suggesting challenges in cash generation relative to net income. The free cash flow to net income ratio is 0.73, showing limited free cash flow generation.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.13B	4.25B	4.49B	5.80B	5.05B	4.64B
Gross Profit	1.63B	1.65B	1.83B	2.33B	2.17B	2.05B
EBITDA	713.00M	737.40M	786.20M	1.30B	1.19B	1.04B
Net Income	99.20M	339.90M	1.32B	736.50M	739.60M	552.40M
Balance Sheet
Total Assets	12.30B	11.65B	11.93B	11.17B	10.58B	10.19B
Cash, Cash Equivalents and Short-Term Investments	438.20M	357.30M	302.40M	572.00M	516.80M	568.90M
Total Debt	4.16B	3.50B	4.11B	3.27B	3.17B	3.27B
Total Liabilities	7.87B	7.14B	7.49B	7.77B	7.53B	7.20B
Stockholders Equity	4.43B	4.49B	4.41B	3.40B	3.05B	2.98B
Cash Flow
Free Cash Flow	-7.30M	603.20M	-520.30M	440.10M	720.00M	580.60M
Operating Cash Flow	61.60M	671.10M	-386.40M	582.40M	820.10M	647.80M
Investing Cash Flow	250.80M	263.60M	-154.40M	-266.40M	-112.00M	-169.30M
Financing Cash Flow	-325.10M	-870.10M	331.50M	-237.40M	-747.90M	-250.30M

FMC Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 30.54
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FMC, the sentiment is Neutral. The current price of 30.54 is above the 20-day moving average (MA) of 30.38, below the 50-day MA of 34.13, and below the 200-day MA of 38.57, indicating a neutral trend. The MACD of -1.05 indicates Negative momentum. The RSI at 41.87 is Neutral, neither overbought nor oversold. The STOCH value of 69.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FMC.

FMC Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CF	―	$13.95B	11.25	24.98%	2.31%	9.53%	36.15%
ICL	―	$8.57B	23.35	6.24%	2.69%	-1.22%	-14.31%
MOS	―	$9.32B	9.96	7.80%	2.94%	-7.71%	297.49%
Sector *	―	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
FMC	―	$3.81B	38.77	2.88%	7.57%	1.16%	-92.85%
SMG	―	$3.23B	72.98	―	4.79%	-2.05%	―
USBC	―	$407.55M	-0.21	―	―	―	42.75%

FMC Corporate Events

FMC Corporation Reports Strong Q2 2025 Results

FMC Corporation is a global agricultural sciences company that provides innovative crop protection solutions, including biologicals, crop nutrition, and digital agriculture, to help growers produce food, feed, fiber, and fuel while adapting to environmental changes.

FMC Corp’s Earnings Call: Growth Amid Challenges

The recent earnings call of FMC Corp presented a balanced sentiment, highlighting both achievements and challenges. Notable regional growth and successful product launches were offset by significant hurdles in India and pricing pressures. The strategic decision to divest the India business underscores FMC’s proactive approach to addressing these challenges. While cost efficiencies and promising new product registrations offer a positive outlook, regional sales declines and pricing adjustments pose ongoing challenges.